Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 176

1.

Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients.

Johansson SL, Wulf-Johansson H, Schlosser A, Titlestad IL, Miller B, Tal-Singer R, Holmskov U, Vestbo J, Sørensen GL.

ERJ Open Res. 2019 Apr 15;5(2). pii: 00021-2019. doi: 10.1183/23120541.00021-2019. eCollection 2019 Apr.

2.

A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study.

Kaur S, Smith LM, Patel A, Menning M, Watley DC, Malik SS, Krishn SR, Mallya K, Aithal A, Sasson AR, Johansson SL, Jain M, Singh S, Guha S, Are C, Raimondo M, Hollingsworth MA, Brand RE, Batra SK.

Am J Gastroenterol. 2017 Jan;112(1):172-183. doi: 10.1038/ajg.2016.482. Epub 2016 Nov 15.

3.

Mucins and associated glycan signatures in colon adenoma-carcinoma sequence: Prospective pathological implication(s) for early diagnosis of colon cancer.

Krishn SR, Kaur S, Smith LM, Johansson SL, Jain M, Patel A, Gautam SK, Hollingsworth MA, Mandel U, Clausen H, Lo WC, Fan WT, Manne U, Batra SK.

Cancer Lett. 2016 May 1;374(2):304-14. doi: 10.1016/j.canlet.2016.02.016. Epub 2016 Feb 16.

4.

MUC5AC interactions with integrin β4 enhances the migration of lung cancer cells through FAK signaling.

Lakshmanan I, Rachagani S, Hauke R, Krishn SR, Paknikar S, Seshacharyulu P, Karmakar S, Nimmakayala RK, Kaushik G, Johansson SL, Carey GB, Ponnusamy MP, Kaur S, Batra SK, Ganti AK.

Oncogene. 2016 Aug 4;35(31):4112-21. doi: 10.1038/onc.2015.478. Epub 2016 Jan 11.

5.

MUC4 regulates cellular senescence in head and neck squamous cell carcinoma through p16/Rb pathway.

Macha MA, Rachagani S, Pai P, Gupta S, Lydiatt WM, Smith RB, Johansson SL, Lele SM, Kakar SS, Farghaly H, Lee JH, Meza J, Ganti AK, Jain M, Batra SK.

Oncogene. 2015 May 21;34(21):2814. doi: 10.1038/onc.2015.116. No abstract available.

PMID:
25994150
6.

Inhibition of hedgehog signaling improves the anti-carcinogenic effects of docetaxel in prostate cancer.

Mimeault M, Rachagani S, Muniyan S, Seshacharyulu P, Johansson SL, Datta K, Lin MF, Batra SK.

Oncotarget. 2015 Feb 28;6(6):3887-903.

7.

NCOA3-mediated upregulation of mucin expression via transcriptional and post-translational changes during the development of pancreatic cancer.

Kumar S, Das S, Rachagani S, Kaur S, Joshi S, Johansson SL, Ponnusamy MP, Jain M, Batra SK.

Oncogene. 2015 Sep 10;34(37):4879-89. doi: 10.1038/onc.2014.409. Epub 2014 Dec 22.

8.

Malignant paraganglioma of the bladder: a case report and review of the literature.

Quist EE, Javadzadeh BM, Johannesen E, Johansson SL, Lele SM, Kozel JA.

Pathol Res Pract. 2015 Feb;211(2):183-8. doi: 10.1016/j.prp.2014.10.009. Epub 2014 Nov 27. Review.

PMID:
25512259
9.

Unbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisation.

Souchek JJ, Baine MJ, Lin C, Rachagani S, Gupta S, Kaur S, Lester K, Zheng D, Chen S, Smith L, Lazenby A, Johansson SL, Jain M, Batra SK.

Br J Cancer. 2014 Sep 9;111(6):1139-49. doi: 10.1038/bjc.2014.385. Epub 2014 Jul 15.

10.

Microfibrillar-associated protein 4: a potential biomarker of chronic obstructive pulmonary disease.

Johansson SL, Roberts NB, Schlosser A, Andersen CB, Carlsen J, Wulf-Johansson H, Sækmose SG, Titlestad IL, Tornoe I, Miller B, Tal-Singer R, Holmskov U, Vestbo J, Sorensen GL.

Respir Med. 2014 Sep;108(9):1336-44. doi: 10.1016/j.rmed.2014.06.003. Epub 2014 Jun 20.

11.

Smoking accelerates pancreatic cancer progression by promoting differentiation of MDSCs and inducing HB-EGF expression in macrophages.

Kumar S, Torres MP, Kaur S, Rachagani S, Joshi S, Johansson SL, Momi N, Baine MJ, Gilling CE, Smith LM, Wyatt TA, Jain M, Joshi SS, Batra SK.

Oncogene. 2015 Apr 16;34(16):2052-60. doi: 10.1038/onc.2014.154. Epub 2014 Jun 9.

12.

MUC4 regulates cellular senescence in head and neck squamous cell carcinoma through p16/Rb pathway.

Macha MA, Rachagani S, Pai P, Gupta S, Lydiatt WM, Smith RB, Johansson SL, Lele SM, Kakar SS, Farghaly H, Lee JH, Meza J, Ganti AK, Jain M, Batra SK.

Oncogene. 2015 Mar 26;34(13):1698-708. doi: 10.1038/onc.2014.102. Epub 2014 Apr 21. Erratum in: Oncogene. 2015 May 21;34(21):2814. Farghaly, H [added].

13.

Surfactant protein D is a candidate biomarker for subclinical tobacco smoke-induced lung damage.

Johansson SL, Tan Q, Holst R, Christiansen L, Hansen NC, Hojland AT, Wulf-Johansson H, Schlosser A, Titlestad IL, Vestbo J, Holmskov U, Kyvik KO, Sorensen GL.

Am J Physiol Lung Cell Mol Physiol. 2014 May 1;306(9):L887-95. doi: 10.1152/ajplung.00340.2013. Epub 2014 Mar 7.

14.

Enzyme-linked immunosorbent assay characterization of basal variation and heritability of systemic microfibrillar-associated protein 4.

Sækmose SG, Schlosser A, Holst R, Johansson SL, Wulf-Johansson H, Tornøe I, Vestbo J, Kyvik KO, Barington T, Holmskov U, Sørensen GL.

PLoS One. 2013 Dec 4;8(12):e82383. doi: 10.1371/journal.pone.0082383. eCollection 2013.

15.

Novel pancreatic cancer cell lines derived from genetically engineered mouse models of spontaneous pancreatic adenocarcinoma: applications in diagnosis and therapy.

Torres MP, Rachagani S, Souchek JJ, Mallya K, Johansson SL, Batra SK.

PLoS One. 2013 Nov 20;8(11):e80580. doi: 10.1371/journal.pone.0080580. eCollection 2013.

16.

Pathogenesis of human hemangiosarcomas and hemangiomas.

Liu L, Kakiuchi-Kiyota S, Arnold LL, Johansson SL, Wert D, Cohen SM.

Hum Pathol. 2013 Oct;44(10):2302-11. doi: 10.1016/j.humpath.2013.05.012.

PMID:
24054722
17.

Long-term follow-up of patients with tumours of the renal pelvis and ureter: how often is a bladder tumour diagnosed after five tumour-free years?

Holmäng S, Johansson SL.

Scand J Urol. 2014 Feb;48(1):65-72. doi: 10.3109/21681805.2013.814706. Epub 2013 Jul 24.

PMID:
23883372
18.

A population-based study of tumours of the renal pelvis and ureter: incidence, aetiology and histopathological findings.

Holmäng S, Holmberg E, Johansson SL.

Scand J Urol. 2013 Dec;47(6):491-6. doi: 10.3109/21681805.2013.795188. Epub 2013 May 2.

PMID:
23634644
19.

Impaired expression of protein phosphatase 2A subunits enhances metastatic potential of human prostate cancer cells through activation of AKT pathway.

Pandey P, Seshacharyulu P, Das S, Rachagani S, Ponnusamy MP, Yan Y, Johansson SL, Datta K, Fong Lin M, Batra SK.

Br J Cancer. 2013 Jun 25;108(12):2590-600. doi: 10.1038/bjc.2013.160. Epub 2013 Apr 18.

20.
21.

Pathobiological implications of MUC4 in non-small-cell lung cancer.

Majhi PD, Lakshmanan I, Ponnusamy MP, Jain M, Das S, Kaur S, Shimizu ST, West WW, Johansson SL, Smith LM, Yu F, Rolle CE, Sharma P, Carey GB, Batra SK, Ganti AK.

J Thorac Oncol. 2013 Apr;8(4):398-407. doi: 10.1097/JTO.0b013e3182829e06.

22.

Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy.

Rachagani S, Torres MP, Kumar S, Haridas D, Baine M, Macha MA, Kaur S, Ponnusamy MP, Dey P, Seshacharyulu P, Johansson SL, Jain M, Wagner KU, Batra SK.

J Hematol Oncol. 2012 Oct 26;5:68. doi: 10.1186/1756-8722-5-68.

23.

Circulating surfactant protein D is associated to mortality in elderly women: a twin study.

Wulf-Johansson H, Thinggaard M, Tan Q, Johansson SL, Schlosser A, Christensen K, Holmskov U, Sorensen GL.

Immunobiology. 2013 May;218(5):712-7. doi: 10.1016/j.imbio.2012.08.272. Epub 2012 Aug 20.

PMID:
22999473
24.

Reciprocal regulation of annexin A2 and EGFR with Her-2 in Her-2 negative and herceptin-resistant breast cancer.

Shetty PK, Thamake SI, Biswas S, Johansson SL, Vishwanatha JK.

PLoS One. 2012;7(9):e44299. doi: 10.1371/journal.pone.0044299. Epub 2012 Sep 5.

25.

Malignant PEComa involving the mandible: report of a unique case.

Untrauer JB, Giannini PJ, Talmon GA, Johansson SL.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Jan;117(1):e3-8. doi: 10.1016/j.oooo.2012.03.018. Epub 2012 Aug 15.

PMID:
22901659
26.

Graviola: a novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering cell metabolism.

Torres MP, Rachagani S, Purohit V, Pandey P, Joshi S, Moore ED, Johansson SL, Singh PK, Ganti AK, Batra SK.

Cancer Lett. 2012 Oct 1;323(1):29-40. doi: 10.1016/j.canlet.2012.03.031. Epub 2012 Apr 1.

27.

Pathobiological implications of the expression of EGFR, pAkt, NF-κB and MIC-1 in prostate cancer stem cells and their progenies.

Mimeault M, Johansson SL, Batra SK.

PLoS One. 2012;7(2):e31919. doi: 10.1371/journal.pone.0031919. Epub 2012 Feb 23.

28.

Small cell carcinoma of the renal pelvis and ureter: clinicopathologic and immunohistochemical features.

Miller RJ, Holmäng S, Johansson SL, Lele SM.

Arch Pathol Lab Med. 2011 Dec;135(12):1565-9. doi: 10.5858/arpa.2010-0690-OA.

PMID:
22129185
29.

Upper urinary tract carcinoma in Lynch syndrome cases.

Crockett DG, Wagner DG, Holmäng S, Johansson SL, Lynch HT.

J Urol. 2011 May;185(5):1627-30. doi: 10.1016/j.juro.2010.12.102. Epub 2011 Mar 21.

PMID:
21419447
30.

Neuroendocrine-type prostatic adenocarcinoma with microsatellite instability in a patient with lynch syndrome.

Wagner DG, Gatalica Z, Lynch HT, Kohl S, Johansson SL, Lele SM.

Int J Surg Pathol. 2010 Dec;18(6):550-3. doi: 10.1177/1066896910379406. Epub 2010 Aug 25.

PMID:
20798067
31.

Simple melanosis of the bladder: a rare entity.

Talmon GA, Khan AU, Koerber RK, Johansson SL.

Int J Surg Pathol. 2010 Dec;18(6):547-9. doi: 10.1177/1066896909352863. Epub 2010 May 5.

PMID:
20444730
32.

MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progenies.

Mimeault M, Johansson SL, Senapati S, Momi N, Chakraborty S, Batra SK.

Cancer Lett. 2010 Sep 1;295(1):69-84. doi: 10.1016/j.canlet.2010.02.015. Epub 2010 Mar 19.

33.

Urethral carcinoma and hyperplasia in male and female B6C3F1 mice treated with 3,3',4,4'-tetrachloroazobenzene (TCAB).

Singh BP, Nyska A, Kissling GE, Lieuallen W, Johansson SL, Malarkey DE, Hooth MJ.

Toxicol Pathol. 2010 Apr;38(3):372-81. doi: 10.1177/0192623310362708. Epub 2010 Mar 16.

34.

Cytotoxic effects induced by docetaxel, gefitinib, and cyclopamine on side population and nonside population cell fractions from human invasive prostate cancer cells.

Mimeault M, Johansson SL, Henichart JP, Depreux P, Batra SK.

Mol Cancer Ther. 2010 Mar;9(3):617-30. doi: 10.1158/1535-7163.MCT-09-1013. Epub 2010 Feb 23.

35.

Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK-RhoA signaling pathway.

Senapati S, Rachagani S, Chaudhary K, Johansson SL, Singh RK, Batra SK.

Oncogene. 2010 Mar 4;29(9):1293-302. doi: 10.1038/onc.2009.420. Epub 2009 Nov 30.

37.

Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells.

Singh AP, Bafna S, Chaudhary K, Venkatraman G, Smith L, Eudy JD, Johansson SL, Lin MF, Batra SK.

Cancer Lett. 2008 Jan 18;259(1):28-38. Epub 2007 Oct 30.

38.

Completeness and correctness of registration of renal pelvic and ureteral cancer in the Swedish Cancer Registry.

Holmäng S, Amsler-Nordin S, Carlson K, Holmberg E, Johansson SL.

Scand J Urol Nephrol. 2008;42(1):12-7. Epub 2007 Aug 2.

PMID:
17853011
39.

Quantitative fluorescence imaging analysis for cancer biomarker discovery: application to beta-catenin in archived prostate specimens.

Huang D, Casale GP, Tian J, Wehbi NK, Abrahams NA, Kaleem Z, Smith LM, Johansson SL, Elkahwaji JE, Hemstreet GP 3rd.

Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1371-81. Epub 2007 Jul 10.

40.

Squamous cell carcinoma of the renal pelvis and ureter: incidence, symptoms, treatment and outcome.

Holmäng S, Lele SM, Johansson SL.

J Urol. 2007 Jul;178(1):51-6. Epub 2007 May 11.

PMID:
17574059
41.

Clinical significance of benign glands at surgical margins in robotic radical prostatectomy specimens.

Kohl SK, Balaji KC, Smith LM, Wilson NP, Johansson SL, Sterrett SP, Abrahams NA.

Urology. 2007 Jun;69(6):1112-6.

PMID:
17572197
42.
43.

Prostate-derived factor as a paracrine and autocrine factor for the proliferation of androgen receptor-positive human prostate cancer cells.

Chen SJ, Karan D, Johansson SL, Lin FF, Zeckser J, Singh AP, Batra SK, Lin MF.

Prostate. 2007 Apr 1;67(5):557-71.

PMID:
17221842
44.

Expression of TAG-72 in ovarian cancer and its correlation with tumor stage and patient prognosis.

Ponnusamy MP, Venkatraman G, Singh AP, Chauhan SC, Johansson SL, Jain M, Smith L, Davis JS, Remmenga SW, Batra SK.

Cancer Lett. 2007 Jun 28;251(2):247-57. Epub 2007 Jan 8.

PMID:
17210225
45.

Impact of diagnostic and treatment delay on survival in patients with renal pelvic and ureteral cancer.

Holmäng S, Johansson SL.

Scand J Urol Nephrol. 2006;40(6):479-84.

PMID:
17130100
46.

Novel combination therapy against metastatic and androgen-independent prostate cancer by using gefitinib, tamoxifen and etoposide.

Mimeault M, Venkatraman G, Johansson SL, Moore E, Henichart JP, Depreux P, Lin MF, Batra SK.

Int J Cancer. 2007 Jan 1;120(1):160-9.

47.

Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125).

Chauhan SC, Singh AP, Ruiz F, Johansson SL, Jain M, Smith LM, Moniaux N, Batra SK.

Mod Pathol. 2006 Oct;19(10):1386-94. Epub 2006 Jul 28.

48.

Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria.

Sarosdy MF, Kahn PR, Ziffer MD, Love WR, Barkin J, Abara EO, Jansz K, Bridge JA, Johansson SL, Persons DL, Gibson JS.

J Urol. 2006 Jul;176(1):44-7.

PMID:
16753364
49.

Micropapillary carcinoma of the renal pelvis and ureter.

Holmäng S, Thomsen J, Johansson SL.

J Urol. 2006 Feb;175(2):463-6; discussion 466-7.

PMID:
16406972
50.

Supplemental Content

Loading ...
Support Center